Invention Application
- Patent Title: COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING MACULAR DEGENERATION
-
Application No.: US17681468Application Date: 2022-02-25
-
Publication No.: US20220288232A1Publication Date: 2022-09-15
- Inventor: Abraham SCARIA
- Applicant: Genzyme Corporation
- Applicant Address: US MA Cambridge
- Assignee: Genzyme Corporation
- Current Assignee: Genzyme Corporation
- Current Assignee Address: US MA Cambridge
- Main IPC: A61K48/00
- IPC: A61K48/00 ; C07K14/71 ; A61K9/00
Abstract:
Compositions and methods for treating macular degeneration are disclosed. The methods utilize gene delivery to human eyes of soluble Flt-1 receptors, as well fusion proteins including a soluble Flt-1 receptor.
Information query
